Advances in chronic kidney disease 2007RONCO, Claudio; LEVIN, Nathan W.Blood purification. 2007, Vol 25, Num 1, issn 0253-5068, 149 p.Conference Proceedings

Advances in end-stage renal diseases 2005RONCO, Claudio; LEVIN, Nathan W.Blood purification. 2005, Vol 23, Num 1, issn 0253-5068, 100 p.Conference Proceedings

Advances in Chronic Kidney Disease 2010KOTANKO, Peter; LEVIN, Nathan W; RONCO, Claudio et al.Blood purification. 2010, Vol 29, Num 2, issn 0253-5068, 169 p.Conference Proceedings

Vascular access monitoring improves outcomesSANDS, Jeffrey J.Blood purification. 2005, Vol 23, Num 1, pp 45-49, issn 0253-5068, 5 p.Conference Paper

Saving infected catheters: Why and howALLON, Michael.Blood purification. 2005, Vol 23, Num 1, pp 23-28, issn 0253-5068, 6 p.Conference Paper

Access monitoring does not really improve outcomesPAULSON, William D.Blood purification. 2005, Vol 23, Num 1, pp 50-56, issn 0253-5068, 7 p.Conference Paper

Vascular access monitoring: Methods and procedures: Something to standardize?LOPOT, Frantisek; NEJEDLY, Bohdan; VALEK, Martin et al.Blood purification. 2005, Vol 23, Num 1, pp 36-44, issn 0253-5068, 9 p.Conference Paper

Phosphate Elimination in Modalities of Hemodialysis and Peritoneal DialysisKUHLMANN, Martin K.Blood purification. 2010, Vol 29, Num 2, pp 137-144, issn 0253-5068, 8 p.Conference Paper

Hyperphosphatemia in renal failureRITZ, Eberhard; GROSS, Marie-Luise.Blood purification. 2005, Vol 23, Num 1, pp 6-9, issn 0253-5068, 4 p.Conference Paper

How to Successfully Achieve Salt Restriction in Dialysis Patients? What Are the Outcomes?OK, Ercan.Blood purification. 2010, Vol 29, Num 2, pp 102-104, issn 0253-5068, 3 p.Conference Paper

C-reactive protein in end-stage renal disease: Are there reasons to measure it?STENVINKEL, Peter; LINDHOLM, Bengt.Blood purification. 2005, Vol 23, Num 1, pp 72-78, issn 0253-5068, 7 p.Conference Paper

Home hemodialysis and remote monitoring: Current technology, requirements and capabilitiesSCHLAEPER, Christian; DIAZ-BUXO, José A.Blood purification. 2005, Vol 23, Num 1, pp 18-22, issn 0253-5068, 5 p.Conference Paper

Aldosterone in Uremia -Beyond Blood PressureRITZ, Eberhard; KOLEGANOVA, Nadezda.Blood purification. 2010, Vol 29, Num 2, pp 111-113, issn 0253-5068, 3 p.Conference Paper

Citrate Anticoagulation for Continuous Renal Replacement Therapy in the Critically IIIOUDEMANS-VAN STRAATEN, Heleen M.Blood purification. 2010, Vol 29, Num 2, pp 191-196, issn 0253-5068, 6 p.Conference Paper

Ethnicity and Renal Replacement TherapyFEEHALLY, John.Blood purification. 2010, Vol 29, Num 2, pp 125-129, issn 0253-5068, 5 p.Conference Paper

Haemodialysis-Induced Myocardial Stunning in Chronic Kidney Disease -A New Aspect of Cardiovascular DiseaseMCLNTYRE, Chris W.Blood purification. 2010, Vol 29, Num 2, pp 105-110, issn 0253-5068, 6 p.Conference Paper

Novel Insights into the Pathobiology of the Vascular Access - Do They Translate into Improved Care?DISKIN, Charles J.Blood purification. 2010, Vol 29, Num 2, pp 216-229, issn 0253-5068, 14 p.Conference Paper

The Therapeutic Potential of Erythropoiesis-Stimulating Agents for Tissue Protection: A Tale of Two ReceptorsBRINES, Michael.Blood purification. 2010, Vol 29, Num 2, pp 86-92, issn 0253-5068, 7 p.Conference Paper

Endothelial Progenitor Cells and Endothelial Vesicles - What Is the Significance for Patients with Chronic Kidney Disease?MOHANDAS, Rajesh; SEGAL, Mark S.Blood purification. 2010, Vol 29, Num 2, pp 158-162, issn 0253-5068, 5 p.Conference Paper

Peritonitis - Does Peritoneal Dialysis Modality Make a Difference?PIRAINO, Beth; SHETH, Heena.Blood purification. 2010, Vol 29, Num 2, pp 145-149, issn 0253-5068, 5 p.Conference Paper

Inflammation and vascular calcificationMOE, Sharon M; CHEN, Neal X.Blood purification. 2005, Vol 23, Num 1, pp 64-71, issn 0253-5068, 8 p.Conference Paper

Immune Mechanisms Involved in Cardiovascular Complications of Chronic Kidney DiseaseSTINGHEN, Andréa E. M; BUCHARLES, Sergio; RIELLA, Miguel C et al.Blood purification. 2010, Vol 29, Num 2, pp 114-120, issn 0253-5068, 7 p.Conference Paper

Modeling Hepatitis C Virus Therapies Combining Drugs and Lectin Affinity PlasmapheresisTULLIS, Richard H; DUFFIN, R. Paul; ICHIM, Thomas E et al.Blood purification. 2010, Vol 29, Num 2, pp 210-215, issn 0253-5068, 6 p.Conference Paper

Novel therapies for hemodialysis vascular access dysfunction: Fact or fiction!ROY-CHAUDHURY, Prabir; KELLY, Burnett S; MELHEM, Murad et al.Blood purification. 2005, Vol 23, Num 1, pp 29-35, issn 0253-5068, 7 p.Conference Paper

The Potential Role of Plasma Gelsolin in Dialysis-Related Protein-Energy WastingPO SHUNLEE; BHAN, Ishir; THADHANI, Ravi et al.Blood purification. 2010, Vol 29, Num 2, pp 99-101, issn 0253-5068, 3 p.Conference Paper